We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Swallowable Robot Pill Could Perform Remote Diagnosis and Treatment of Illness within GI Tract

By HospiMedica International staff writers
Posted on 15 Mar 2022
Print article
Image: The Endiatx PillBot (Photo courtesy of Endiatx)
Image: The Endiatx PillBot (Photo courtesy of Endiatx)

Endoscopy, which involves inserting a camera directly into an organ for examination, is often an expensive and unpleasant procedure, and also carries risks, such as perforation of the stomach or damage to soft tissue. Now, a remote-controlled pill-sized robotic capsule that can be swallowed by patients could perform remote diagnosis of illness within the GI tract, followed by treatments beginning with biopsy, cauterization of bleeds, and removal of polyps.

Endiatx (Redwood City, CA, USA) is developing a pill-sized robot to explore and perform work inside the body, starting with the GI tract. Endiatx’s PillBot could make for cheaper, more efficient endoscopy by allowing the procedure to be performed without the patient having to go to the doctor’s office. The small PillBot robotic device can be sent to a patient’s home and a medical professional can remotely pilot it to efficiently scan the body. The ingestible pill will allow doctors to view the digestive tract without the need for cables or complex procedures, thus reducing patient discomfort as well as making it easier for doctors. The ability of doctors to actively control the diagnostic robot revolutionizes the possibilities for both diagnostics and treatment options as compared to the current types of "capsule endoscopy" sensors and cameras, which can only move passively through the GI tract.

Endiatx’s technology centers around the company’s unique propulsion system which allows its pill robot to actively navigate the entire length of the GI tract in approximately 30 minutes with real-time video control. This allows the device to compete directly with traditional endoscopes and colonoscopies and replace them with a non-invasive process that does not require sedation. The company believes that the GI tract is the appropriate environment to debut its propulsion technology and envisions future generations of the company’s platform being used to take diagnostics and treatment throughout the body. According to the company, a remote surgical platform inside the body can be as big of a leap forward as minimally invasive laparoscopic surgery was to the traditional surgical cutdown.

In the future, Endiatx’s pill robot could allow microsurgery to be performed at home with the surgeon controlling the device from the office. Endiatx also expects its pill robots to take tissue samples and allow for scopes that would detect early-stage pancreatic cancer. Endiatx has already successfully demonstrated an in-human trial of PillBot by providing a live swallow demo of the robotic capsule.

Related Links:
Endiatx 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Computerized Spirometer
DatospirAira

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.